Ginkgo Bioworks Holdings (DNA) — Financial Flexibility Index
Ginkgo Bioworks Holdings (DNA) has a Financial Flexibility Index of -0.08x as of June 2026. Free cash flow of $-43.74 Million (operating CF $-46.36 Million minus capex $2.62 Million) represents 0% of total liabilities ($569.76 Million). Check tangible equity quality of Ginkgo Bioworks Holdings to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ginkgo Bioworks Holdings Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Ginkgo Bioworks Holdings across 7 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Ginkgo Bioworks Holdings.
Annual Financial Flexibility Index for Ginkgo Bioworks Holdings (2019–2025)
Year-by-year free cash flow to debt coverage for Ginkgo Bioworks Holdings. Explore cash flow to debt ratio of Ginkgo Bioworks Holdings to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | $-163.39 Million | $-171.06 Million | $611.11 Million | ▲ +31.2% |
| 2024 | -0.39x | $-257.04 Million | $-319.58 Million | $661.39 Million | ▲ +13.3% |
| 2023 | -0.45x | $-254.70 Million | $-295.50 Million | $568.19 Million | ▼ -80.1% |
| 2022 | -0.25x | $-199.93 Million | $-252.20 Million | $803.04 Million | ▲ +36.5% |
| 2021 | -0.39x | $-197.30 Million | $-253.82 Million | $503.61 Million | ▼ -3.0% |
| 2020 | -0.38x | $-78.01 Million | $-135.83 Million | $205.10 Million | ▼ -231.2% |
| 2019 | -0.11x | $-22.44 Million | $-44.66 Million | $195.47 Million | — |